zantac

Published on: September 20, 2021

Mass Tort Injury Claims: The Focus Should Be On Individuals

I recently read an article which indicated almost 2/3 of all injured plaintiffs in mass tort cases were unhappy. That’s no surprise! Many of these individuals suffered very serious injuries only to be lost in a system that treats them like numbers rather than people. The article discusses a study by Georgia Law Professor Elizabeth Burch and Federal Judicial Center visiting scholar Margaret Williams.

What is a mass tort? I’ll use the ongoing Zantac injury claims as an example. Zantac was a drug distributed across the United States for many, many years. You could even buy Zantac without a prescription for many years. The claim is that Zantac is defective and causes cancer. You have a common product used by everyone. But, the injuries (cancer in this case) are unique. Every person suffers uniquely and individually. Our office has filed several Zantac personal injury claims. Each of our clients is unique and deserves individual attention.

How are these mass tort claims handled? Our Federal Courts will typically assign the cases to a single judge for pre-trial purposes like discovery. The idea is that it saves time and resources for a single judge to oversee all pre-trial issues. Once your individual claim is ready for trial, it will be transferred back to the Federal Court where you filed the case. You get a trial on your unique injuries and damages. At least, in theory, that’s how it is supposed to work. The process is called Multi-District Litigation (MDL).

Continue reading →

Published on: July 5, 2021

Zantac Personal Injury Claims — A Case Update

By Jeff Blackwell

In the last week, our office has filed a number of new zantac personal injury cases. We are also continuing to investigate other potential zantac claims for our Alabama clients. So, I thought it was a good time to provide an update on the zantac injury litigation.

The Judge Continues To Move Zantac Injury Lawsuits Forward

In a recent Pre-Trial Order, the Federal Judge overseeing zantac injury claims addressed the selection of bellwether cases for trial. If you have already filed a claim, this is a good signal the court is pushing the litigation forward.

Continue reading →

Published on: January 4, 2021

Injured By A Defective Drug? New Case Reminds Plaintiffs Of Important Legal Hurdle!

By Jeff Blackwell

On December 22, the 11th Circuit issued a new opinion dealing with the Learned Intermediary Doctrine under Georgia law. Many states, including Alabama, follow the same or similar versions of this doctrine. The Learned Intermediary Doctrine is a key issue in personal injury cases involving dangerous or defective prescription medications. If you suffered a serious injury from a bad drug, this legal doctrine may decide whether or not you can recover damages for your injuries.

What Is The LEARNED INTERMEDIARY DOCTRINE? How The Doctrine Impacts Bad Medication Cases.

So, what is the learned intermediary doctrine? Let’s start with the new 11th Circuit case, Hubbard v. Bayer Healthcare Pharmaceuticals. The case involved a Georgia lady who suffered a catastrophic stroke while taking the prescription contraceptive Beyaz. Later, she sued Bayer claiming the company failed to warn adequately of the stroke risk.

Continue reading →

Published on: October 5, 2020

Zantac — The Chemical NDMA Causes Cancer

By Jeff Blackwell

Heartburn. Acid Reflux. For years, drug companies marketed Ranitidine (Zantac) as a miracle drug. Drug companies even advertised the drug as a lifestyle drug allowing patients to continue eating heartburn-causing foods. What was the cost of this miracle drug that produced blockbuster profits? The public is now learning how ranitidine breaks down into the chemical NDMA, a toxic cancer-causing chemical. How many innocent consumers may have suffered life-threatening cancer injuries from the drug? It’s a topic I’ve discussed in several articles.

For an overview of Ranitidine (Zantac) claims, you can read my article titled Zantac Cancer Injuries. I published the article on our law firm website. My article provides an overview of the drug Zantac, its history and its relationship to cancer-causing NDMA.

The drug Ranitidine (Zantac) reacts with acid in the stomach as well as enzymes in other organs to chemically create NDMA in the human body. For more in-depth discussion about Ranitidine and how the drug chemically produces carcinogenic NDMA, you can read my blog post titled Four Ways Zantac Causes Cancer. I’ve also written some other articles following the growing research and ongoing litigation involving Zantac and multiple cancer injuries. You can read those articles on this blog.

Continue reading →

Published on: September 10, 2020

Four Ways Zantac (Ranitidine) Leads To Cancer

By Jeff Blackwell

I’ve written several articles discussing Ranitidine (brand name Zantac) and cancer injuries. For a longer discussion on the background and history of Zantac, you can click the link and read our report at Zantac Cancer Lawsuits. I’ve also written several other Zantac articles which you can read on the Blackwell Law Firm Blog. We will continue to follow the growing Zantac research linking the drug to cancer injuries.

In my prior articles, I provided an overview of NDMA — the cancer causing substance associated with Zantac. No safe level of NDMA exists. NDMA is highly toxic. Ranitidine (Zantac) breaks down to create toxic, cancer-causing NDMA. In recent years, our firm has handled Alabama injury cases involving several different cancer-causing medications. But, Zantac is especially dangerous. Why? What makes Zantac so dangerous is that it breaks down in more than one way to put consumers at risk of injury. In other words, Ranitidine reacts in multiple ways to produce cancer causing NDMA. Here, are four ways Ranitidine leads to cancer-causing NDMA that can harm you:

RANITIDINE LEADS TO CANCER-CAUSING NDMA FORMATION IN THE HUMAN STOMACH

Continue reading →

Published on: August 17, 2020

When Prescription Medications Cause Cancer

By Jeff Blackwell

We trust our medications are safe. They should be. After all, the medications we use are approved by the Food & Drug Administration (FDA). Yet, some prescription medications cause tremendous personal injuries or deaths to patients. In some cases, drug companies withhold research or even mislead the FDA into approving their products. When that happens, doctors and patients only learn the truth after years of needless suffering.

In recent years, we’ve learned that some common medications may actually cause cancer. I’ll give three recent examples of popular medications linked to cancer — two from current investigations by our firm and one from a prior case. With some medications, we must ask: Does the harm of some medications far outweigh their benefit?

Belviq (Current Cases)

Continue reading →

Published on: June 15, 2020

Zantac And Cancer: Court Indicates It Will Study Relationship

By Jeff Blackwell

We are closely following developments in the Zantac (Ranitidine) injury litigation. In recent months, our office has started investigating numerous potential cancer injury cases involving the drug.

What makes Zantac dangerous? How is Ranitidine (as Zantac is known generically) linked to numerous cancers? For detailed information, you can read a couple articles I’ve written on the drug and its link to cancers. You can find them here:

Zantac Cancer Lawsuits – You can find this article in the Hot Topics section of our law firm website. It is a lengthy article where I discuss the drug, how it works and its association with potential cancer. As I discuss in the article, Zantac contains NDMA which is a highly carcinogenic compound.

Continue reading →

Published on: April 18, 2020

Zantac Pulled From Shelves Due To Cancer Risks

By Jeff Blackwell

On April 1, 2020, the U.S. Food & Drug Administration (FDA) requested that manufacturers withdraw ALL prescription and over-the-counter ranitidine drugs immediately. Here is how the FDA began its announcement:

The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately.

What is ranitidine? You may know this medication as Zantac, its brand name.

Continue reading →